Here are the DEF 14A proxy statements from Healthcare AI Acq CP A (HAIAF) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow HAIAF and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HAIAF filings page.
Healthcare AI Acquisition Corp. (HAIAF) asks shareholders to approve a month-to-month extension of its business-combination deadline from October 14, 2026, to October 14, 2027, with deposits of $0.10 per non-redeemed Public Share per month into the Trust Account. If approved, sponsor Atticus Ale LLC has indicated it will provide each monthly amount as an interest-free loan, repayable upon a business combination. The extension would allow more time for a proposed combination with Leading Group Limited; shareholders are not voting on that combination at this meeting.
As of September 29, 2026, the Trust Account held approximately $1,842,381.93, and the estimated redemption price was approximately $14.26 per Public Share. The virtual meeting is scheduled for October 13, 2026; approval requires a special resolution supported by at least two-thirds of holders voting in person or by proxy. If the proposal fails, HAIA says it will stop operations and redeem 100% of Public Shares as promptly as reasonably possible, but no more than 10 business days later, subject to available funds and applicable law. HAIA securities were suspended from Nasdaq on December 17, 2024, and currently trade OTC.